At Robins Kaplan LLP, our antitrust and trade regulation attorneys provide an innovative and sophisticated approach to antitrust counseling and litigation. We are one of the few national practices to have obtained notable successes on behalf of both plaintiffs and defendants in major antitrust litigation and at trial. Our recent groundbreaking $7.25 billion class action settlement against Visa, MasterCard, and major U.S. banks relating to Interchange Fees and Merchant Point-of-Sale Rules is the largest ever for a private antitrust case. On the other side of the courtroom, we successfully defended UnitedHealth Group and PacifiCare in an antitrust lawsuit involving alleged price fixing and fraud related to prescription drug reimbursement under the federal Medicare Part D program, with claimed damages in excess of $1 billion. Our attorneys also represent parties in government investigations and actions, including both investigation targets and complainants, and counsel clients on the antitrust risks associated with contemplated transactions. Our antitrust litigation experience has touched on nearly every aspect of the Sherman and Clayton Acts, including monopolization, price discrimination, price fixing, territorial restraints, bid rigging, exclusive dealing, tying, boycotts, RICO, unfair competition, and unfair trade practices.